SlideShare a Scribd company logo
Contract and Consumer law
   Thalidomide first appeared in Germany in October
    1957

   The drug was introduced to the UK
    in 1958 under its brand name
    Distaval.

   The drug was mainly given to pregnant women for
    morning sickness.

   On 27 November 1961 Thalidomide was withdrawn in
    the UK from the British manufacture Distillers
    Biochemical LTD.
   The first British thalidomide victim was born
    in January 1959.

   There are currently 455 thalidomide survivors
    in the UK.

   In 1976 it was revealed that Distillers had not
    met the basic testing requirements of the
    time.
   The victim's disabilities range from
    missing limbs and internal
    deformities.

   it is estimated around 40% of thalidomide
    victims died before their first birthday.

   The Thalidomide Trust was established in
    August 1973, to provide support
   Sue for tort of negligence – civil law

   High court – Queen’s Bench

   First case Donoghue v Stevenson 1932

   Must prove duty of care and breach of duty i.e.
    fault

   The Congenital Disabilities (Civil Liability) Act
    1976 – duty of care owed to unborn child
   Breach of duty hard to prove – what would other
    manufacturers have done? Had they taken all
    reasonable care?

   Daniels v White & Son – 14 year old girl sniffing
    bottles of lemonade – breach of duty not proved

   Difficult /impossible to prove breach – Distillers
    would claim they tested product as any other
    manufacturer would have done – drug was
    licensed

   Any compensation – out of court settlement
   Now strict tortious liability under Consumer
    Protection Act 1984 part 1

   No need to prove fault

   But state of art defence would allow manufacturer to
    escape liability

   State of scientific and technical knowledge –
    manufacturer would only have to carry out tests
    known at the time and those that other
    manufacturers would carry out

   Claim would still fail
   The parents of British Thalidomiders were forced to
    fight a protracted court battle for compensation.

   In 1968 a deal was negotiated with Distillers which
    gave 62 victims compensation in an out of court
    settlement (40% of what they might have won if court
    case had been successful)

   After 1968 many out of court settlements followed

   "Y-list“ - 98 children who were suspected of suffering
    deformities due to the drug, but who could not prove
    it and so were unable to claim compensation.
   In 1972, The Sunday Times published the first in a series of
    articles under the headline “Our Thalidomide Children: a Cause
    for National Shame”

   An injunction was issued to stop the campaign

   The Sunday Times then decided to fight the injunction on its
    investigation into the origins and testing of the drug.

 The case went right through the British legal system and up to
  the European Court of Human Rights, which decided that the
  injunction violated the right of “freedom of expression”.
http://www.hrcr.org/safrica/limitations/sunday_times_uk.html
   1973 after 11 year campaign Distillers agreed to pay
    £20 million and to set up a trust fund for victims

   In 2005 Distillers, now part of Diageo, agreed an
    extra one-off payment worth 70% of the annual
    payments

   In 2010 Government issues long-awaited apology
    and a new £20m compensation package to 466
    thalidomiders

   Currently in the UK victims receive, on average
    £18,000 a year

More Related Content

What's hot

INTERNATIONAL NON PROPRIETARY NAMES FOR DRUGS1.pptx
INTERNATIONAL NON PROPRIETARY NAMES FOR DRUGS1.pptxINTERNATIONAL NON PROPRIETARY NAMES FOR DRUGS1.pptx
INTERNATIONAL NON PROPRIETARY NAMES FOR DRUGS1.pptxE Poovarasan
 
Federal food, drug & cosmetics act
Federal food, drug & cosmetics actFederal food, drug & cosmetics act
Federal food, drug & cosmetics actJamia Hamdard
 
Pharmacovigilance and ICH guidlines
Pharmacovigilance and ICH guidlinesPharmacovigilance and ICH guidlines
Pharmacovigilance and ICH guidlineschandroo80
 
CDSCO- Functions & Responsibilities
CDSCO- Functions & ResponsibilitiesCDSCO- Functions & Responsibilities
CDSCO- Functions & ResponsibilitiesBindu Kshtriya
 
ICH safety guidelines
ICH safety guidelinesICH safety guidelines
ICH safety guidelinesvishnu Jatoth
 
Regulatory Affairs.
Regulatory Affairs.Regulatory Affairs.
Regulatory Affairs.Naila Kanwal
 
International nonproprietary names
International nonproprietary namesInternational nonproprietary names
International nonproprietary namesAltacit Global
 
Clinical Trials Introduction
Clinical Trials IntroductionClinical Trials Introduction
Clinical Trials Introductionbiinoida
 
2. unit II, chapter-2 regulatory authorities and agencies.
2. unit II, chapter-2 regulatory authorities and agencies.2. unit II, chapter-2 regulatory authorities and agencies.
2. unit II, chapter-2 regulatory authorities and agencies.Audumbar Mali
 
Defined daily dose-DDD
Defined daily dose-DDDDefined daily dose-DDD
Defined daily dose-DDDMubasheeraMg
 
Cdsco Roles and Responsibilities
Cdsco Roles and ResponsibilitiesCdsco Roles and Responsibilities
Cdsco Roles and ResponsibilitiesSandip Mavchi
 
ICH Guidelines for Pharmacovigilance
ICH Guidelines for PharmacovigilanceICH Guidelines for Pharmacovigilance
ICH Guidelines for PharmacovigilanceDr. Ramesh Bhandari
 
Good Clinical Practice and Pharmacovigilance
Good Clinical Practice and PharmacovigilanceGood Clinical Practice and Pharmacovigilance
Good Clinical Practice and PharmacovigilanceMd. Zakaria Faruki
 
Methods of causality assessment
Methods of causality assessmentMethods of causality assessment
Methods of causality assessmentthennarasu palani
 
Belmont report
Belmont reportBelmont report
Belmont reportPradeep H
 

What's hot (20)

Pharmacovigilance
PharmacovigilancePharmacovigilance
Pharmacovigilance
 
New drug development
New drug developmentNew drug development
New drug development
 
INTERNATIONAL NON PROPRIETARY NAMES FOR DRUGS1.pptx
INTERNATIONAL NON PROPRIETARY NAMES FOR DRUGS1.pptxINTERNATIONAL NON PROPRIETARY NAMES FOR DRUGS1.pptx
INTERNATIONAL NON PROPRIETARY NAMES FOR DRUGS1.pptx
 
Federal food, drug & cosmetics act
Federal food, drug & cosmetics actFederal food, drug & cosmetics act
Federal food, drug & cosmetics act
 
Pharmacovigilance and ICH guidlines
Pharmacovigilance and ICH guidlinesPharmacovigilance and ICH guidlines
Pharmacovigilance and ICH guidlines
 
CDSCO- Functions & Responsibilities
CDSCO- Functions & ResponsibilitiesCDSCO- Functions & Responsibilities
CDSCO- Functions & Responsibilities
 
ICH safety guidelines
ICH safety guidelinesICH safety guidelines
ICH safety guidelines
 
History of Clinical Trials
History of Clinical TrialsHistory of Clinical Trials
History of Clinical Trials
 
Regulatory Affairs.
Regulatory Affairs.Regulatory Affairs.
Regulatory Affairs.
 
International nonproprietary names
International nonproprietary namesInternational nonproprietary names
International nonproprietary names
 
Clinical Trials Introduction
Clinical Trials IntroductionClinical Trials Introduction
Clinical Trials Introduction
 
2. unit II, chapter-2 regulatory authorities and agencies.
2. unit II, chapter-2 regulatory authorities and agencies.2. unit II, chapter-2 regulatory authorities and agencies.
2. unit II, chapter-2 regulatory authorities and agencies.
 
Defined daily dose-DDD
Defined daily dose-DDDDefined daily dose-DDD
Defined daily dose-DDD
 
Cdsco Roles and Responsibilities
Cdsco Roles and ResponsibilitiesCdsco Roles and Responsibilities
Cdsco Roles and Responsibilities
 
ICH Guidelines for Pharmacovigilance
ICH Guidelines for PharmacovigilanceICH Guidelines for Pharmacovigilance
ICH Guidelines for Pharmacovigilance
 
Good Clinical Practice and Pharmacovigilance
Good Clinical Practice and PharmacovigilanceGood Clinical Practice and Pharmacovigilance
Good Clinical Practice and Pharmacovigilance
 
Methods of causality assessment
Methods of causality assessmentMethods of causality assessment
Methods of causality assessment
 
Pharmacovigilance Basics
Pharmacovigilance BasicsPharmacovigilance Basics
Pharmacovigilance Basics
 
Belmont report
Belmont reportBelmont report
Belmont report
 
CDSCO- CENTRAL DRUG STANDARD CONTROL ORGANISATION
CDSCO- CENTRAL DRUG STANDARD CONTROL ORGANISATIONCDSCO- CENTRAL DRUG STANDARD CONTROL ORGANISATION
CDSCO- CENTRAL DRUG STANDARD CONTROL ORGANISATION
 

Viewers also liked

Thalidomide & its derivatives by Dr. Harmanjit Singh, Department of Pharmacol...
Thalidomide & its derivatives by Dr. Harmanjit Singh, Department of Pharmacol...Thalidomide & its derivatives by Dr. Harmanjit Singh, Department of Pharmacol...
Thalidomide & its derivatives by Dr. Harmanjit Singh, Department of Pharmacol...Govt Medical College & Hospital, Sector-32
 
Chiral Separation A pharma Industry Perspective
Chiral Separation A pharma Industry PerspectiveChiral Separation A pharma Industry Perspective
Chiral Separation A pharma Industry PerspectiveBhaswat Chakraborty
 
Pharmacovigilance ppt
Pharmacovigilance pptPharmacovigilance ppt
Pharmacovigilance pptPrasad Bhat
 
Who art & med dra
Who art & med draWho art & med dra
Who art & med draPlessan Joy
 
Propuesta rise thalidomide.ppt felix valles
Propuesta rise thalidomide.ppt felix vallesPropuesta rise thalidomide.ppt felix valles
Propuesta rise thalidomide.ppt felix vallesyanielisrodriguez
 
Devitalisation of Thalidomide
Devitalisation of ThalidomideDevitalisation of Thalidomide
Devitalisation of ThalidomideDr Yugandar
 
Spatial distributiion mapping of drinking water fluoride levels in Karnataka....
Spatial distributiion mapping of drinking water fluoride levels in Karnataka....Spatial distributiion mapping of drinking water fluoride levels in Karnataka....
Spatial distributiion mapping of drinking water fluoride levels in Karnataka....Chitta Chowdhury
 
Thalidomide The Irish Experience Presentation2
Thalidomide The Irish Experience Presentation2Thalidomide The Irish Experience Presentation2
Thalidomide The Irish Experience Presentation2Carmel Daly
 
Pharmacovigilance at Trauma Center, AIIMS
Pharmacovigilance at Trauma Center, AIIMSPharmacovigilance at Trauma Center, AIIMS
Pharmacovigilance at Trauma Center, AIIMSDr.Sharad H. Gajuryal
 
Ethics of scientific research rc d ec 2014
Ethics of scientific research rc d ec 2014Ethics of scientific research rc d ec 2014
Ethics of scientific research rc d ec 2014researchcenterm
 
Shraddha pre on 3 r new presen 123
Shraddha pre on 3 r new presen 123Shraddha pre on 3 r new presen 123
Shraddha pre on 3 r new presen 123shraddha khairnar
 
How to present a poster (1)
How to present a poster (1)How to present a poster (1)
How to present a poster (1)researchcenterm
 
Pharmacotherapy considerations in elderly adults
Pharmacotherapy considerations in elderly adultsPharmacotherapy considerations in elderly adults
Pharmacotherapy considerations in elderly adultsSafaa Ali
 
Role of Enantiomers in Pharmacology
Role of Enantiomers in PharmacologyRole of Enantiomers in Pharmacology
Role of Enantiomers in PharmacologyDr. Prashant Shukla
 
Receptor down regulation
Receptor down regulationReceptor down regulation
Receptor down regulationChander K Negi
 
Receptor regulation and diseases
Receptor regulation and diseasesReceptor regulation and diseases
Receptor regulation and diseasesPLESSAN
 

Viewers also liked (20)

Thalidomide & its derivatives by Dr. Harmanjit Singh, Department of Pharmacol...
Thalidomide & its derivatives by Dr. Harmanjit Singh, Department of Pharmacol...Thalidomide & its derivatives by Dr. Harmanjit Singh, Department of Pharmacol...
Thalidomide & its derivatives by Dr. Harmanjit Singh, Department of Pharmacol...
 
thalidomide
thalidomidethalidomide
thalidomide
 
Chiral Separation A pharma Industry Perspective
Chiral Separation A pharma Industry PerspectiveChiral Separation A pharma Industry Perspective
Chiral Separation A pharma Industry Perspective
 
Pharmacovigilance ppt
Pharmacovigilance pptPharmacovigilance ppt
Pharmacovigilance ppt
 
Who art & med dra
Who art & med draWho art & med dra
Who art & med dra
 
Propuesta rise thalidomide.ppt felix valles
Propuesta rise thalidomide.ppt felix vallesPropuesta rise thalidomide.ppt felix valles
Propuesta rise thalidomide.ppt felix valles
 
Devitalisation of Thalidomide
Devitalisation of ThalidomideDevitalisation of Thalidomide
Devitalisation of Thalidomide
 
Spatial distributiion mapping of drinking water fluoride levels in Karnataka....
Spatial distributiion mapping of drinking water fluoride levels in Karnataka....Spatial distributiion mapping of drinking water fluoride levels in Karnataka....
Spatial distributiion mapping of drinking water fluoride levels in Karnataka....
 
Thalidomide The Irish Experience Presentation2
Thalidomide The Irish Experience Presentation2Thalidomide The Irish Experience Presentation2
Thalidomide The Irish Experience Presentation2
 
Pharmacovigilance at Trauma Center, AIIMS
Pharmacovigilance at Trauma Center, AIIMSPharmacovigilance at Trauma Center, AIIMS
Pharmacovigilance at Trauma Center, AIIMS
 
Geriatr007
Geriatr007Geriatr007
Geriatr007
 
يصثيصيص ي
يصثيصيص ييصثيصيص ي
يصثيصيص ي
 
Assignment on isomerism
Assignment on isomerismAssignment on isomerism
Assignment on isomerism
 
Ethics of scientific research rc d ec 2014
Ethics of scientific research rc d ec 2014Ethics of scientific research rc d ec 2014
Ethics of scientific research rc d ec 2014
 
Shraddha pre on 3 r new presen 123
Shraddha pre on 3 r new presen 123Shraddha pre on 3 r new presen 123
Shraddha pre on 3 r new presen 123
 
How to present a poster (1)
How to present a poster (1)How to present a poster (1)
How to present a poster (1)
 
Pharmacotherapy considerations in elderly adults
Pharmacotherapy considerations in elderly adultsPharmacotherapy considerations in elderly adults
Pharmacotherapy considerations in elderly adults
 
Role of Enantiomers in Pharmacology
Role of Enantiomers in PharmacologyRole of Enantiomers in Pharmacology
Role of Enantiomers in Pharmacology
 
Receptor down regulation
Receptor down regulationReceptor down regulation
Receptor down regulation
 
Receptor regulation and diseases
Receptor regulation and diseasesReceptor regulation and diseases
Receptor regulation and diseases
 

Similar to Thalidomide

Reputation Management
Reputation ManagementReputation Management
Reputation Managementm_gill
 
Tobacco Tort Litigation
Tobacco Tort LitigationTobacco Tort Litigation
Tobacco Tort Litigationtsesa
 
Global Harmonization Issues and the Protection of Intellectual Property
Global Harmonization Issues and the Protection of Intellectual PropertyGlobal Harmonization Issues and the Protection of Intellectual Property
Global Harmonization Issues and the Protection of Intellectual PropertyMichael Swit
 
Legal and Ethical Constraints in the Creative Media Sector
Legal and Ethical Constraints in the Creative Media SectorLegal and Ethical Constraints in the Creative Media Sector
Legal and Ethical Constraints in the Creative Media Sectoremilyaldredd
 
SOC 204 Goldberg ch 4 f2f Fall15
SOC 204 Goldberg ch 4 f2f Fall15SOC 204 Goldberg ch 4 f2f Fall15
SOC 204 Goldberg ch 4 f2f Fall15Michelle Meyer
 
Cameron Diver Summary of International Arbitration Experience
Cameron Diver Summary of International Arbitration ExperienceCameron Diver Summary of International Arbitration Experience
Cameron Diver Summary of International Arbitration ExperienceCameron Diver
 
Introduction to the regulatory affairs
Introduction to the regulatory affairsIntroduction to the regulatory affairs
Introduction to the regulatory affairsChandra Mohan
 
8.advert.2020.online
8.advert.2020.online8.advert.2020.online
8.advert.2020.onlineBill Kovarik
 
Concerns over national security and the environment led congress to .docx
Concerns over national security and the environment led congress to .docxConcerns over national security and the environment led congress to .docx
Concerns over national security and the environment led congress to .docxladonnacamplin
 
James M. Cooper and Bashar H. Malkawi, The need to relax intellectual propert...
James M. Cooper and Bashar H. Malkawi, The need to relax intellectual propert...James M. Cooper and Bashar H. Malkawi, The need to relax intellectual propert...
James M. Cooper and Bashar H. Malkawi, The need to relax intellectual propert...Bashar H. Malkawi
 
GSIPA2M, Parallel session 2, Making compulsory licenses routine - James Love
GSIPA2M, Parallel session 2, Making compulsory licenses routine - James LoveGSIPA2M, Parallel session 2, Making compulsory licenses routine - James Love
GSIPA2M, Parallel session 2, Making compulsory licenses routine - James LoveMakeMedicinesAffordable
 
Federal hazardous substances act
Federal hazardous substances actFederal hazardous substances act
Federal hazardous substances actSaurabh Mishra
 
Multiple-Choice 2 points each.Pick the best answer; put answers .docx
Multiple-Choice 2 points each.Pick the best answer; put answers .docxMultiple-Choice 2 points each.Pick the best answer; put answers .docx
Multiple-Choice 2 points each.Pick the best answer; put answers .docxadelaidefarmer322
 
Soc 204 Goldberg Chapter 4 Drugs & The Law
Soc 204 Goldberg Chapter 4 Drugs & The LawSoc 204 Goldberg Chapter 4 Drugs & The Law
Soc 204 Goldberg Chapter 4 Drugs & The LawMichelle Cottrell
 

Similar to Thalidomide (20)

Breast Implants
Breast ImplantsBreast Implants
Breast Implants
 
Reputation Management
Reputation ManagementReputation Management
Reputation Management
 
1 gmp essentials
1 gmp essentials1 gmp essentials
1 gmp essentials
 
Tobacco Tort Litigation
Tobacco Tort LitigationTobacco Tort Litigation
Tobacco Tort Litigation
 
Global Harmonization Issues and the Protection of Intellectual Property
Global Harmonization Issues and the Protection of Intellectual PropertyGlobal Harmonization Issues and the Protection of Intellectual Property
Global Harmonization Issues and the Protection of Intellectual Property
 
NEGLIGENCE17[2].ppt
NEGLIGENCE17[2].pptNEGLIGENCE17[2].ppt
NEGLIGENCE17[2].ppt
 
Legal and Ethical Constraints in the Creative Media Sector
Legal and Ethical Constraints in the Creative Media SectorLegal and Ethical Constraints in the Creative Media Sector
Legal and Ethical Constraints in the Creative Media Sector
 
History & Evolution of GMP Regulations
History & Evolution of GMP RegulationsHistory & Evolution of GMP Regulations
History & Evolution of GMP Regulations
 
Tobacco conspiracy
Tobacco conspiracyTobacco conspiracy
Tobacco conspiracy
 
SOC 204 Goldberg ch 4 f2f Fall15
SOC 204 Goldberg ch 4 f2f Fall15SOC 204 Goldberg ch 4 f2f Fall15
SOC 204 Goldberg ch 4 f2f Fall15
 
Cameron Diver Summary of International Arbitration Experience
Cameron Diver Summary of International Arbitration ExperienceCameron Diver Summary of International Arbitration Experience
Cameron Diver Summary of International Arbitration Experience
 
Introduction to the regulatory affairs
Introduction to the regulatory affairsIntroduction to the regulatory affairs
Introduction to the regulatory affairs
 
8.advert.2020.online
8.advert.2020.online8.advert.2020.online
8.advert.2020.online
 
Concerns over national security and the environment led congress to .docx
Concerns over national security and the environment led congress to .docxConcerns over national security and the environment led congress to .docx
Concerns over national security and the environment led congress to .docx
 
James M. Cooper and Bashar H. Malkawi, The need to relax intellectual propert...
James M. Cooper and Bashar H. Malkawi, The need to relax intellectual propert...James M. Cooper and Bashar H. Malkawi, The need to relax intellectual propert...
James M. Cooper and Bashar H. Malkawi, The need to relax intellectual propert...
 
GSIPA2M, Parallel session 2, Making compulsory licenses routine - James Love
GSIPA2M, Parallel session 2, Making compulsory licenses routine - James LoveGSIPA2M, Parallel session 2, Making compulsory licenses routine - James Love
GSIPA2M, Parallel session 2, Making compulsory licenses routine - James Love
 
Federal hazardous substances act
Federal hazardous substances actFederal hazardous substances act
Federal hazardous substances act
 
Multiple-Choice 2 points each.Pick the best answer; put answers .docx
Multiple-Choice 2 points each.Pick the best answer; put answers .docxMultiple-Choice 2 points each.Pick the best answer; put answers .docx
Multiple-Choice 2 points each.Pick the best answer; put answers .docx
 
Liability round up - january 2010
Liability round up - january 2010Liability round up - january 2010
Liability round up - january 2010
 
Soc 204 Goldberg Chapter 4 Drugs & The Law
Soc 204 Goldberg Chapter 4 Drugs & The LawSoc 204 Goldberg Chapter 4 Drugs & The Law
Soc 204 Goldberg Chapter 4 Drugs & The Law
 

Thalidomide

  • 2. Thalidomide first appeared in Germany in October 1957  The drug was introduced to the UK in 1958 under its brand name Distaval.  The drug was mainly given to pregnant women for morning sickness.  On 27 November 1961 Thalidomide was withdrawn in the UK from the British manufacture Distillers Biochemical LTD.
  • 3. The first British thalidomide victim was born in January 1959.  There are currently 455 thalidomide survivors in the UK.  In 1976 it was revealed that Distillers had not met the basic testing requirements of the time.
  • 4. The victim's disabilities range from missing limbs and internal deformities.  it is estimated around 40% of thalidomide victims died before their first birthday.  The Thalidomide Trust was established in August 1973, to provide support
  • 5. Sue for tort of negligence – civil law  High court – Queen’s Bench  First case Donoghue v Stevenson 1932  Must prove duty of care and breach of duty i.e. fault  The Congenital Disabilities (Civil Liability) Act 1976 – duty of care owed to unborn child
  • 6. Breach of duty hard to prove – what would other manufacturers have done? Had they taken all reasonable care?  Daniels v White & Son – 14 year old girl sniffing bottles of lemonade – breach of duty not proved  Difficult /impossible to prove breach – Distillers would claim they tested product as any other manufacturer would have done – drug was licensed  Any compensation – out of court settlement
  • 7. Now strict tortious liability under Consumer Protection Act 1984 part 1  No need to prove fault  But state of art defence would allow manufacturer to escape liability  State of scientific and technical knowledge – manufacturer would only have to carry out tests known at the time and those that other manufacturers would carry out  Claim would still fail
  • 8. The parents of British Thalidomiders were forced to fight a protracted court battle for compensation.  In 1968 a deal was negotiated with Distillers which gave 62 victims compensation in an out of court settlement (40% of what they might have won if court case had been successful)  After 1968 many out of court settlements followed  "Y-list“ - 98 children who were suspected of suffering deformities due to the drug, but who could not prove it and so were unable to claim compensation.
  • 9. In 1972, The Sunday Times published the first in a series of articles under the headline “Our Thalidomide Children: a Cause for National Shame”  An injunction was issued to stop the campaign  The Sunday Times then decided to fight the injunction on its investigation into the origins and testing of the drug.  The case went right through the British legal system and up to the European Court of Human Rights, which decided that the injunction violated the right of “freedom of expression”. http://www.hrcr.org/safrica/limitations/sunday_times_uk.html
  • 10. 1973 after 11 year campaign Distillers agreed to pay £20 million and to set up a trust fund for victims  In 2005 Distillers, now part of Diageo, agreed an extra one-off payment worth 70% of the annual payments  In 2010 Government issues long-awaited apology and a new £20m compensation package to 466 thalidomiders  Currently in the UK victims receive, on average £18,000 a year